Back to results
US 11,890,279 B2Granted
Quinolines that modulate SERCA and their use for treating disease
AssigneeNeurodon Corporation
InventorRussell Dahl
Life of this patent
Estimating the term…
Abstract
Provided herein are compounds of Formula I, pharmaceutical compositions thereof, and methods of their use for treating, preventing, or ameliorating one or more symptoms of a neurological disease, neurodegenerative disorder, or diabetes.
Claims4
A method of treating a subject with diabetes, comprising administering to the subject an effective amount of a compound represented by the following structural formula:
- or a pharmaceutically acceptable salt, solvate, or hydrate thereof.
Dependencies are inferred from the claim text.